08ÖÐɽ´óÍâ¿Æ¿¼²©ÌâÄ¿ >+BLD
LZPLz@=&]
Ò»¡¢¼ò´ðÌ⣺ cTJG1'm
££1¡¢¼òÊöÍâ¿ÆÓªÑø´úл²¢·¢Ö¢ÓÐÄÄЩ£¿ *fDhNmQ `
££2¡¢¼òÊöÍâ¿Æ¸ÐȾÁªºÏ¿¹Ñ×µÄÊÊÓ¦Ö¢¡£ Yv;iduc('
££3¡¢¼òÊöÆÆÉË·çµÄ´¦ÀíÔÔò¡£ oFJx8XU
££4¡¢¼òÊö¸¹²¿ÇпÚÁÑ¿ªµÄÖ÷ÒªÔÒò¡£ÓкαíÏÖ£¿ or
F8
%
££5¡¢¼òÊö Fast track surgery ¼°Ä¿µÄÓëÖ÷Òª´ëÊ©¡£ i;<H^\%
££6¡¢¼òÊöÊÖ±ÛÏ´ÊÖÏû¶¾ºóΪºÎ»¹Ðè´÷Ïû¶¾ÊÖÌ×£¿ :jWQev"/
££7¡¢Ê²Ã´ÊÇ BMI £¿ÈçºÎ²âËã¼°¶ÔÓªÑø×´Ì¬Õï¶ÏµÄ±ê×¼£¿ 5,V3_p:)VI
££8¡¢°ü¾¥¿ÉÄÜ´øÀ´ÄÇЩΣº¦£¿ sr$JFMTO11
¶þ¡¢ÎÊ´ðÌ⣺£¨Ñ¡Ëù±¨×¨Òµ£© ,3ivB8
£¨ÆÕͨÍâ¿Æ£© A3e83g~L
££16¡¢µ¨ÄÒ°©µÄ Nevin ·ÖÆÚÒÔ¼°ÊÖÊõ·½·¨¡£ Pu]Pp`SP
££17¡¢PPH µÄ¸ÅÄî¡¢ÔÀí¡¢ÊÖÊõÊÊÓ¦Ö¢¼°Óŵ㡣 SnW>`
£¨ÐÄÐØÍâ¿Æ£© &q[`lIV, L
££18¡¢³£¼ûµÄ¿ÉÐÐÍâ¿ÆÊÖÊõ¸ùÖεÄÏÈÌìÐÔÐÄÔಡ£¨²»ÉÙÓÚ 7 ÖÖ£©¼°·¨ÂåËÄÁªÖ¢µÄËÄÖÖ»ûÐΡ£ NHzhGg]
££19¡¢Ó°Ïìʳ¹Ü°©Íâ¿ÆÖÎÁÆÔ¶ÆÚЧ¹ûµÄÖ÷ÒªÒòËØÓÐÄÄЩ£¿ X[iQ%Y$/n
£¨ÉÕÉËÍâ¿Æ£© .\ces2,
££20¡¢ñ£ºÛÔöÉúµÄ¿ÉÄÜÒòËØ¡£ <bOi }
££21¡¢ÉÕÉËÐÝ¿ËÆÚÇÐðèµÄ±ØÒªÐÔ¡£ QK/~lN
£¨¹Ç¡¢ÏÔ΢Íâ¿Æ£© I.}E#f/A'
££22¡¢ÏÈÌìÐÔÂíÌãÄÚ·×ãÖÎÁÆÔÔò¡£ 1A\N$9Dls
££23¡¢¹É¹ÇͷȱѪÐÔ»µËÀµÄ Ficat ·ÖÆÚ¡£ +dSO?
Y]
£¨Éñ¾Íâ¿Æ£© w97%5[-T
££24¡¢´¹ÌåÔ´ÐÔ Cushing¡®s disease ÄÚ·ÖÃÚѧ¼ì²éµÄÁÙ´²ÒâÒå¡£ S_56!
££25¡¢£*****lasgow Liege Coma Scale £¬GLCS£©¸ñÀ˹¸ç-À³¼ª»èÃԼƷַ½·¨ºÍÁÙ´²ÒâÒå¡£ 8d"Ff
£¨ÒÆÖ²Íâ¿Æ) jG&gd<^
££26¡¢ÄÇЩÒòËØÓ°ÏìÉöÒÆÖ²Ð§¹û£¿ LYyOcb[x
££27¡¢¸ÎÒÆÖ²¼±ÐÔÅųⷴӦÓÐÄÄЩ²¡ÀíÑ§ÌØÕ÷£¿ C.;H?So(
£¨ÃÚÄòÍâ¿Æ£©
UB1/0o
££28¡¢ÓÕ·¢ÃÚÄòÉúֳϵ¸ÐȾµÄÒòËØÖ÷Òª°üÀ¨ÄÇЩ·½Ã棿 2i_k$
-
£££££ÃÚÄòÍâ¿Æ³£ÓÃÄÄЩÕï¶ÏÐÔÆ÷е¼ì²é£¿ x\R
8W8M
££29¡¢Éö°©¿ÉÄܳöÏÖÄÄЩÉöÍâµÄÁÙ´²±íÏÖ£¿ =L&}&pT
£££££Êȸõϸ°ûÁöµÄÊõǰ׼±¸Ó¦°üÀ¨ÄÄЩÄÚÈÝ£¿ &ywU^hBh
£¨Ð¡¶ùÍâ¿Æ£© jUCrj
'
££30¡¢ÏÈÌìÐÔµ¨¹ÜÀ©ÕÅÖ¢ÄÒÖ×ÐÍÓëËóÐÍ¡¢Öù×´ÐÍÔÚ²¡ÒòºÍ²¢·¢Ö¢·½ÃæÓÐʲô²»Í¬£¿ f&
>[$zh
£££££ÏÈÌìÐÔµ¨¹ÜÀ©ÕÅÖ¢ÊÖÊõ·½·¨ÈçºÎÑ¡Ôñ£¿ K_sHZ
££31¡¢Ð¡¶ùÏÈÌìÐÔÉö»ýË®µÄ³£¼û²¿Î»¡¢ÔÒò¡¢¼°ÁÙ´²Ö¢×´£¬ s xp>9&
£££££B³¬¡¢CT¡¢MRIºÍ¾²ÂöÉöÓÛÔìÓ°µÄ×÷Óᣠ8%D 2G i
7[? {wbq
2008ÄêÖÐɽÈËÌå½âÆÊѧ¿¼²©ÊÔÌ⣬רҵ»ù´¡ y)e8pPDG
i917d@r( <
Ò»¡¢¼ò´ðÌ⣺ U}2b{
1¡¢¼òÊöÊäÂѹܵķֲ¿¼°¸÷²¿Ìص㡣 R-V4Ju[:
2¡¢¼òÊöÊÕ¼¡¹ÜµÄ×é³É¡¢Î»Öü°ÄÚÈÝ¡£ nL@(|nJ[
3¡¢¼òÊöÃæÉñ¾ÂÍâ¶ÎµÄÐг̡£ %RS8zN
4¡¢ÊÔÊöÒí´ÔµÄ½âÆÊÌØµã¡£ =9AX\2w*H;
5¡¢ÊÓ¾õ¡¢Ìý¾õ¸ÐÊÜÆ÷ÊÇʲô£¿ Z0I>PBL@l
¼òÊöÆä´«µ¼Â·Óм¸¼¶Éñ¾Ôª¼°ÆäÖ÷ҪλÖᣠ)UgLs|G~
6¡¢ÁгöÄÔ¸ÉÖÐÖ÷ÒªÖм̺ËÍŵÄÃû³Æ¡¢Î»Öü°ÆäÖ÷Òª¹¦ÄÜ¡£ B
LI
9(@
¶þ¡¢ÎÊ´ðÌ⣺ Oq3]ZUVa
1¡¢ÊÔÊö¸ÎÍ⵨µÀµÄ×é³ÉºÍ¸÷²¿½á¹¹Ìص㡣 4V9S~^v|
2¡¢ÊÔÊö×µ¹ÜµÄ¹¹³É¡¢ÄÚÈÝÎï¼°ÁÙ´²ÒâÒå¡£ 6./3w&D;
3¡¢ÏêÊöÐØÇ»ÔàÆ÷µÄÁܰͻØÁ÷ºÍÁܰͽáµÄ·Ö²¼¡£ T>2_ r6;
4¡¢ÊÔÊö¾±¸ù²¿µÄ½âÆÊ½á¹¹¡£ ]d]rV
`RF
5¡¢ÊÔÊöÄÔѪ¹ÜµÄ×é³É¼°Æä½á¹¹Ìص㡣 +<1MY'>
y
6¡¢ºÎνÉÏ¡¢ÏÂÔ˶¯Éñ¾Ôª£¿ lrL:v~g
ÈôËðÉ˺óÆäÁÙ´²±íÏÖÓкÎÒìͬ£¿ yrVk$k#6}
7U,[Ruu
2008ÄêÖÐɽҽ¿Æ´óѧ²¡ÀíÉúÀíÊÔÌâ :[C"}mR1
bs9X4n5
Ò»¡¢Ãû´Ê½âÊÍ£ºÃ¿Ìâ5·Ö£¬¹²20·Ö GI _.[
1¡¢acute phase protein,AP; !5XH.DYq!
2¡¢DIC 6k-
3¡¢pulmonary encephalopathy _(%;O:i
4¡¢renal osteodystrophy [ q
x[ 0
¶þ¡¢ÎÊ´ðÌ⣺ÿÌâ20·Ö VY|'7in"M
1¡¢³ÖÐø¡¢³¤ÆÚÉñ¾£ÌåÒº´ú³¥µ¼ÖÂÐÄË¥µÄ»úÖÆ£» DP5}q"l
2¡¢¾ÙÀý˵Ã÷¶à¸ö»·½ÚÐźŴ«µ¼Òì³£Óë¼²²¡£» Yw_^]:~
3¡¢ÐÝ¿Ëʱϸ°ûËðÉË£» O=;}VZ<9
4¡¢´úËá¶ÔÐÄѪ¹ÜϵͳµÄÓ°Ï죻 tR`^c8gD
cy
@",z
08ÖÐɽ²©Ê¿²¡Àí רҵ»ù´¡ ;:A/WU.^
Ãû½â sRKoM
1.Apoptosis 2.chronic granulomatous inflammation 3.CIN 4.Langerhans' cell %("WoBPH`
>,}SP;
histiocytosis 5.tuberculoma 6.pseudolobuli 7.protooncogene 8qF OO3c\V
¼ò´ð GMW,
+
1.¼òÊöÒìÐÍÐÔ "p\5:<
2¶¯ÂöÖàÑù²¡±äÆÚ²¡ÀíÌØµã Bb9/nsbE
3.Ôλ·Ö×ÓÔÓ½»ÊÇʲô?ÔÀíºÍÌØµã? _y5J]Yu`j
4.°å²ãÐ͸Îϸ°û°©µÄÐÎÌ¬Ñ§ÌØÕ÷ +b_o2''
5.Á¼¶ñÐÔÖ×ÁöµÄ¼ø±ð U]}f]GK
6.¶¯ÂöÖàÑù°ß¿éµÄÐÎÌ¬Ñ§ÌØÕ÷ 'gv~M_
ÎÊ´ð 1.IEs:(;
1.EB²¡¶¾Ïà¹ØÐÔÖ×Áö?·Ö±ðÃèÊöÆä²¡ÀíÌØÕ÷ A(6n- zL
2.Ô°©»ùÒòºÍ°©»ùÒòÓÐÊ²Ã´Çø±ð?¼¤»î»úÖÆºÍ²úÉúµÄµ°°×Òò×Ó¼°×÷ÓÃ,¾ÙÀý˵Ã÷ h;DLD8L
3.·Ç»ôÆæ½ðÁܰÍÁöµÄÖ÷Òª·ÖÐÍ,Çë·Ö±ð˵Ã÷ÃâÒß×é»¯ÌØÕ÷? |!hN!j*)
4.Ô·¢ÐÔ¿ÅÁ£ÐÔ¹ÌËõÉöµÄ³ÉÒò?¼ø±ðÕï¶Ï? C7Ny-rj}IA
5
-2#H?:U
£²£°£°£¸ÖÐɽ²©Ê¿²¡ÀíÊÔ¾í£¨×¨Òµ£© @5tGI U;1
v\3$$T)
Ãû´Ê½âÊÍ£» KybrSa
Aschoff body 05s{Z.aK
hydatidiform mole $iMbtA5aQ
Real-time =.(~`ici~
PCR .!Q*VTW
mirror image cell ^^(!>n6r^
Occult lung cancer /zg|I?$>Z4
councilman body * _@t$W
Teratoma granulocytic sarcoma iCIU'yI
Telomeres BFvRU5&Sz
FISH %4^NX@1jV
½â´ð: sh)[|?7z
1¡¢ÏÙÁöÑùÏ¢È⣬¼ø±ðÕï¶ÏÒªµã?
s`I]>e
2¡¢CGH»ù±¾ÔÀí£¬ÌØµã£¿ jg\FD51$
3¡¢ÈéÏÙÏËάÏÙÁö£¬ÏËάÄÒÐÔÈéÏÙ²¡µÄ´óÌå¡¢¾µÏ¡¢ÉúÎïѧÐÎΪ²îÒ죿 |"aop|
4¡¢¾ÙÀý£º¼Ò×åÒÅ´«ÐÔÖ×ÁöÆð¹Ø¼ü×÷ÓõĻùÒò£¿ t{W
u5<F:
5¡¢¶þ¼â°êÏÁÕʱ£¬ÑªÁ÷¶¯Á¦Ñ§ºÍÐÄÔà¸Ä±ä£¿ w)Z-, J
6¡¢PCR£SSCP¼¼Êõ»ù±¾ÔÀí¼°ÌØµãÊÇʲô£¿ CfEACH4_
ÎÊ´ð bx:j`5Uj`
1¡¢Ð¡Ï¸°ûÐÔ¶ñÐÔÖ×ÁöÓÐÄÄЩ£¬ÏéÊöÈýÖÖÖ×ÁöµÄÐÎÌ¬ÌØÕ÷¼°¼ø±ð·½·¨£¿ cceh`s=cU
2¡¢RNAiÊÇʲô£¿ËüµÄÔÀí¼°ÔÚ¶ñÐÔÖ×ÁöÖÎÁÆÖеÄÓ¦ÓÃǰ¾°£¿ :wY(</H
3¡¢Óɸ÷ÖÖ¾ÕÐÎÍÅÐγɵÄÖÐÊàÉñ¾ÏµÍ³Ö×ÁöµÄ·¢²¡²¿Î»¡¢ÄêÁä¡¢¾µÏ¼°ÃâÒß×黯·´Ó¦Òìͬ£¿ Nin7AOO
4¡¢×óÊÒ¸½±ÚѪ˨ÐγÉÔÒò¡¢ÐÎ̬¼°¶Ô»úÌåµÄÓ°Ï죿 Aa}Nr5{O|
L XHDX
ÖÐɽ08²©Ê¿´«È¾ºÍÃâÒß ZmAo
9>'Kg
R 6
-RH7.
ÃâÒߣºÈ«ÊÇ´óÌ⣺ y`a]##1j$M
1.ÊÔÊöDCµÄÌØÕ÷ v~:'t\n
2.ÔõÑùÖÆ×÷¸ßЧ¼ÛÃâÒßѪÇå ",pd 9
3.ÊÔÊöTHϸ°ûµÄ·ÖÀಢ¾Ù³öÁ½ÖÖÒÔÉϲ»Í¬THϸ°û½éµ¼µÄ¼²²¡ cv"Bhql
4.ÒÔ²¡¶¾¸ÐȾΪÀý£¬ÊÔÊö»úÌåÃâÒßϵͳÊÇÔõÑù¿¹¸ÐȾµÄ &0RKNpwg
5. @y8)
"m"
´«È¾²¡£º F4$9r^21r
Ãû´Ê½âÊÍ£ºMRSA ALI ³¦ð¤Ä¤¾ùȺ PYyT#AcW2
ÎÊ´ðÌߣº1.í¦³æ²¡µÄ¼ø±ðÕï¶Ï \[<8AV"E-'
2.ÄÔÄÒβòʵÄÁÙ´²±íÏÖ WZN0`Od
3.µÇ¸ïÈȵÄÕï¶Ï ^_t7{z%sA[
4.ÊÔÊöºË¸ÉÀàÒ©ÎïÔÚ¿¹ÒҸβ¡¶¾ÖеÄÓ¦Óà g3TqTs
5.´«È¾²¡²¡Ôѧ¼ì²é·½·¨ +Uxtxl'
B8>3GZi
{w mP
08ÉϺ£½»´óÍâ¿Æ£¨ÆÕÍ⣩²©Ê¿¿¼Ìâ
C:p`
1.Ãû½â£º ~\u~>mtchu
×éÖ¯¹¤³Ìѧ¡¢SIRS¡¢ARDS¡¢½»½çÖ×Áö¡¢MODS¡¢Ã×ÊÏ×ÛºÏÕ÷ qPn!.m$/
2.Ìî¿Õ o'=i$Eb
TPN²¢·¢Ö¢£º glZjo
×éÖ¯ÐÞ¸´½×¶Î£º R'$1,ie
»ùÒò¹¤³Ì¹ý³Ì£º H8h,JBg5<F
Ѫѹ¿ØÖÆÔÔò£º ;CDa*(e
µ¨µÀ³öѪÈýÁªÕ÷£º +HEL ^
ѪҺÖлº³å¶Ô£º $KPf[JvQ
ÉöÔàµ÷½ÚËá¼îƽºâµÄ»úÀí£º /2Bf6
3.Îʴ𣺠yAQ)/u[|
¸ÎÔàÓ¦ÓýâÆÊ£» 9s#*~[E*
¼±ÐÔÒÈÏÙÑ×ÊÖÊõÔÔò£» :.crES7<[X
Ö×Áö¸ùÖÎÔÔò£» wUH:l
TPN²¢·¢Ö¢¼°ÔÒò¡£ *~^M_wej
y<m}dW6[\
ÉϺ£Í¬¼Ã´óѧ08Ä꿼²©ÄڿƺͲ¡Éú &XB1=b5
ÄÚ¿ÆÑ§£º W.>}5uVl6
±Ø´ðÌ⣺ IYe ,VL
Ãû½â£º1ºôÎü˯ÃßÔÝÍ£×ÛºÏÕ÷£»2¼±ÐÔ¹ÚÂö×ÛºÏÕ÷£»3ACEIµÄÊÊÓ¦Ö¢ºÍ½û¼ÉÖ¤£» UQq Qim
4ÒõÀë×Ó¼ä϶£» F@1Eg
¼ò´ð£º£±£Á£Ì£É£¯£Á£Ò£Ä£ÓµÄÕï¶Ï±ê×¼¼°´¦Àí£» +@MG$*}Oz
£²È±ÌúÐÔÆ¶Ñª»¼Õ߿ڷþÌú¼ÁÎÞЧµÄÒòËØÓÐÄÄЩ£» .=@CF8ArG
£³ÒȵºËØÇ¿»¯ÖÎÁƺó»¼ÕßÔçÉϿڷþѪÌǽµµÍµÄÔÒò¼°´¦Àí£» e|4U2\&3y
£´¸ÎÓ²»¯ÃÅÂö¸ßѹ֢µÄÖ÷ÒªÁÙ´²±íÏÖ£» =z#j9'n$@
£µ£Ó£Ì£ÅµÄÕï¶Ï±ê×¼£» " (yw(/
ÎÊ´ðÌ⣺ ese?;1
r
£±·Î˨ÈûµÄÕï¶ÏºÍ´¦Àí£» |fPR7-
£²ÂýÐÔ³ÖÐøÐÔ·¿²üµÄÖÎÁÆÔÔò£» 89ab?H}/
£³Ð£ËÀºóÖ÷Òª²¢·¢Ö¢ÓÐÄÄЩ¼°´¦Àí´ëÊ©£» yK w.69.
£´Ñ×Ö¢ÐÔ³¦²¡ÊÇʲô²¡£¬¼ø±ðÒªµã£» ,p6o "-
£µÉö²¡×ÛºÏÕ÷µÄÕï¶Ï±ê×¼ºÍ´¦ÀíÔÔò£¬ÒýÆðÉö²¡×ÛºÏÕ÷µÄ¼Ì·¢ÐÔÉöСÇò¼²²¡ÓÐÄÄЩ£» 6f&qtJQ<A
ÒÔÉÏÊDZشðÌ⣬£µ£°·Ö£»»¹Óи÷¿ÆÊÒµÄÑ¡´ðÌ⣬£µ£°·Ö£» 4B@Ir)^(*
ºôÎü²¡Ñ§Ñ¡´ðÌ⣺ 4)d"}j
Ãû½â£º£±¡¢£Â£Ð£Ô£»£²¡¢£Õ£Á£Ã£Ó£»£³¡¢£Ð£Á£È£»£´¡¢£Á£È£É£»£µ¡¢£Ð£Ô£Å£» X yD*V;.E
¼ò´ð£º1¿ÈËÔ±äÒìÐÔÏø´µÄÕï¶Ï±ê×¼£» ^@;P -0Sy
2ÌØ·¢ÐÔ¼äÖÊÐÔ·ÎÑ×µÄÓÐÄÄЩÀàÐÍ£» ~y1k2n
3 ÍüÁË GE}>{x=^x
ÎÊ´ðÌ⣺1HAPºÍCAPµÄÇø±ð£» RH"EO4
2ARDSµÄ»úÐµÍ¨Æø²ßÂÔ£» $`_xP1bUT
+[Q`I*C
²¡Éú£º v(^;%
Ñ¡ÔñÂÔ ]Mj N)%hT
Ãû½â£º1Ðݿˣ»2ARDS£»3Ðļ¡ÒÖÖÆÒò×Ó£»4·¢ÈÈ£»5¸ß¼ØÑªÖ¢£» >uJU25)|
6ȱѪ-ÔÙ¹à×¢ËðÉË£»7µÈÉøÐÔÍÑË®£»8¼ÙÐÔÉñ¾µÝÖÊ£» s:^Xtox/
9³¦Ô´ÐÔ×Ï礣»10ÏÞÖÆÐÔÍ¨ÆøÕϰ£» -o YJ&r
ÎÊ´ð£º1ÐÝ¿ËÍíÆÚÒײ¢·¢DICµÄ»úÖÆ£» Go PK. E$
2¼±ÐÔÉöË¥µÄ·¢Éú»úÖÆ£» G,X
UMZ
3µÍ¼ØÑªÖ¢ÓëÑÏÖØ¸ß¼ØÊ±¹Ç÷À¼¡ÐË·ÜÐÔ½µµÍµÄ»úÖÆ£» W=2#Q2)
4ÂýÐÔºôÎüË¥½ßΪʲôÄÜÒýÆðÐÄË¥¡£ goc"+K
5·Ê´óÐļ¡·¢ÉúË¥½ßµÄ»úÖÆ